Gorgui Dieng is doing incredible things in Senegal
By Ian Levy
The Timberwolves’ Gorgui Dieng is using his fortune and fame to make a huge impact back home in his native Senegal.
You may not know Gorgui Dieng for his work on the court. He averaged just 16.9 minutes per game for the Timberwolves this season, offering size, energy, defensive acumen and a smooth mid-range jumper. His quiet on-court presence belies an enormous off-court impact though. Over the past few years, Dieng has been working overtime, using his NBA salary and influence to help effect change in his native Senegal
Dieng has been working with MATTER, a Minneapolis non-profit, on a number of initiatives, which the Timberwolves recently highlighted in this inspiring video.
In March, Dieng and MATTER teamed up for an event in Minneapolis that raised over $500,000 for for health care and agriculture projects in Senegal.
According to NBA.com, MATTER and Dieng’s foundation have shipped seven containers of medical supplies to the hospital in Kebemer. The idea of Dieng’s NBA salary simply being used to pay medical bills for Senegalese who can’t afford to pay them themselves is incredibly moving. In addition, MATTER and Dieng’s foundation, “partnered with the Roger and Nancy McCabe Foundation to equip a new dialysis center in Dakar, and worked with Gorgui to design and implement a demonstration farm utilizing ecologically sustainable practices to increase yields and provide food for the community. It is estimated that 360,000 lives have been touched through these efforts.”
Next: The Encyclopedia of Modern Moves
These efforts are reminiscent of the work Dikembe Mutombo has done in the Congo. It was recently announced that Mutombo would receive the Sager Strong Award for his courage, compassion and grace, to be presented at the NBA’s official award show on June 25. Mutombo’s foundation works to improve the health, education and quality of life for residents of the Congo and helped open the Biamba Marie Mutombo Hospital in 2007, which has already treated over 250,000 patients.